title: Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.
abstract: BACKGROUND
  Both recurrent and population specific mutations have been found in different areas of the world and more specifically in ethnically defined or isolated populations. The population of Slovenia has over several centuries undergone limited mixing with surrounding populations. The current study was aimed at establishing the mutation spectrum of BRCA1/2 in the Slovenian breast/ovarian cancer families taking advantage of a complete cancer registration database. A second objective was to determine the cancer phenotype of these families.
  
  
  METHODS
  The original population database was composed of cancer patients from the Institute of Oncology Ljubljana in Slovenia which also includes current follow-up status on these patients. The inclusion criteria for the BRCA1/2 screening were: (i) probands with at least two first degree relatives with breast and ovarian cancer; (ii) probands with only two first degree relatives of breast cancer where one must be diagnosed less than 50 years of age; and (iii) individual patients with breast and ovarian cancer, bilateral breast cancer, breast cancer diagnosed before the age of 40 and male breast cancer without any other cancer in the family.
  
  
  RESULTS
  Probands from 150 different families met the inclusion criteria for mutation analysis of which 145 consented to testing. A BRCA1/2 mutation was found in 56 (39%). Two novel large deletions covering consecutive exons of BRCA1 were found. Five highly recurrent specific mutations were identified (1806C>T, 300T>G, 300T>A, 5382insC in the BRCA1 gene and IVS16-2A>G in the BRCA2 gene). The IVS16-2A>G in the BRCA2 gene appears to be a unique founder mutation in the Slovenian population. A practical implication is that only 4 PCR fragments can be used in a first screen and reveal the cancer predisposing mutation in 67% of the BRCA1/2 positive families. We also observed an exceptionally high frequency of 4 different pathogenic missense mutations, all affecting one of the cryptic cysteine residues of the BRCA1 Ring Finger domain.
  
  
  CONCLUSIONS
  A high mutation detection rate and the frequent occurrence of a limited array of recurring mutations facilitate BRCA1/2 mutation screening in Slovenian families.
authors.affiliation: Institute of Oncology Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia. mkrajc@onko-i.si
authors.forename: Mateja
authors.initials: M
authors.lastname: Krajc
authors.forename: Erik
authors.initials: E
authors.lastname: Teugels
authors.forename: Janez
authors.initials: J
authors.lastname: Zgajnar
authors.forename: Guido
authors.initials: G
authors.lastname: Goelen
authors.forename: Nikola
authors.initials: N
authors.lastname: Besic
authors.forename: Srdjan
authors.initials: S
authors.lastname: Novakovic
authors.forename: Marko
authors.initials: M
authors.lastname: Hocevar
authors.forename: Jacques
authors.initials: J
authors.lastname: De Grève
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000235:genetics*; D018567:Breast Neoplasms, Male / Q000235:genetics; D004252:DNA Mutational Analysis; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D005838:Genotype; D006801:Humans; D008297:Male; D009154:Mutation; D020125:Mutation, Missense; D009386:Neoplastic Syndromes, Hereditary / Q000235:genetics*; D010051:Ovarian Neoplasms / Q000235:genetics; D010641:Phenotype; D017384:Sequence Deletion; D017524:Slovenia
references.citation: J Med Genet. 2004 Mar;41(3):e23
references.pmid: 14985394
references.citation: Nat Genet. 1997 Jan;15(1):103-5
references.pmid: 8988179
references.citation: J Med Genet. 1997 Nov;34(11):884-8
references.pmid: 9391879
references.citation: J Med Genet. 1999 Apr;36(4):304-8
references.pmid: 10227398
references.citation: Lab Invest. 2003 Mar;83(3):387-96
references.pmid: 12649339
references.citation: Clin Genet. 2003 Dec;64(6):502-8
references.pmid: 14986830
references.citation: Nat Genet. 1996 May;13(1):117-9
references.pmid: 8673089
references.citation: Fam Cancer. 2004;3(1):1-10
references.pmid: 15131399
references.citation: Nature. 1995 Dec 21-28;378(6559):789-92
references.pmid: 8524414
references.citation: Nat Genet. 1995 Jun;10(2):208-12
references.pmid: 7663517
references.citation: Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1251-4
references.pmid: 11097234
references.citation: Fam Cancer. 2005;4(2):77-84
references.pmid: 15951956
references.citation: Int J Cancer. 2000 Jun 1;86(5):737-40
references.pmid: 10797299
references.citation: Curr Opin Struct Biol. 1996 Jun;6(3):395-401
references.pmid: 8804826
references.citation: N Engl J Med. 1997 May 15;336(20):1409-15
references.pmid: 9145677
references.citation: Breast Cancer Res. 2000;2(4):307-10
references.pmid: 11056688
references.citation: Nat Genet. 1997 Nov;17(3):341-5
references.pmid: 9354803
references.citation: Oncol Rep. 1999 Nov-Dec;6(6):1435-8
references.pmid: 10523726
references.citation: Hum Mutat. 1998;12(3):215
references.pmid: 10660329
references.citation: Eur J Cancer. 2000 Oct;36(16):2083-9
references.pmid: 11044645
references.citation: Int J Cancer. 1999 Sep 24;83(1):5-9
references.pmid: 10449599
references.citation: JAMA. 1997 Mar 26;277(12):997-1003
references.pmid: 9091675
references.citation: Br J Cancer. 2000 Apr;82(7):1266-70
references.pmid: 10755399
references.citation: Br J Cancer. 2000 Sep;83(6):737-42
references.pmid: 10952777
references.citation: Hum Mutat. 2001 Aug;18(2):163-4
references.pmid: 11462242
references.citation: N Engl J Med. 1997 May 15;336(20):1401-8
references.pmid: 9145676
references.citation: BMC Cancer. 2006 Jun 09;6:156
references.pmid: 16764716
references.citation: Int J Cancer. 1998 Nov 23;78(5):581-6
references.pmid: 9808526
references.citation: Nat Genet. 1995 Dec;11(4):428-33
references.pmid: 7493024
references.citation: Science. 1994 Oct 7;266(5182):66-71
references.pmid: 7545954
references.citation: Cancer. 1981 Jun 1;47(11):2730-9
references.pmid: 7260865
references.citation: Hum Mutat. 2006 Jul;27(7):654-66
references.pmid: 16683254
references.citation: Am J Hum Genet. 1998 Mar;62(3):676-89
references.pmid: 9497246
references.citation: Eur J Hum Genet. 2002 Dec;10(12):879-82
references.pmid: 12461697
references.citation: Breast Cancer Res. 2005;7(5):R728-36
references.pmid: 16168118